Elixinol Wellness Ltd (EXL) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.246x

Based on the latest financial reports, Elixinol Wellness Ltd (EXL) has a cash flow conversion efficiency ratio of -0.246x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.83 Million ≈ $-1.30 Million USD) by net assets (AU$7.45 Million ≈ $5.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Elixinol Wellness Ltd stock valuation for the company's overall valuation and market capitalisation.

Elixinol Wellness Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Elixinol Wellness Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Elixinol Wellness Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Elixinol Wellness Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Elixinol Wellness Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Blue Label Telecoms Ltd JSE:BLU	0.456x
EZGO Technologies Ltd NASDAQ:EZGO	-0.047x
Impax Environmental Markets PLC LSE:IEM	0.007x
Aker Carbon Capture ASA OL:ACC	-0.772x
Helios Underwriting PLC LSE:HUW	-0.486x
Rubico Inc. Common Stock NASDAQ:RUBI	-0.050x
Resource Base Ltd AU:RBX	-0.169x
Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret AS IS:LINK	0.021x

Annual Cash Flow Conversion Efficiency for Elixinol Wellness Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Elixinol Wellness Ltd from 2002 to 2025. View Elixinol Wellness Ltd stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$7.45 Million ≈ $5.27 Million	AU$-3.21 Million ≈ $-2.27 Million	-0.431x	-24.65%
2024-12-31	AU$10.03 Million ≈ $7.09 Million	AU$-3.47 Million ≈ $-2.45 Million	-0.346x	+18.93%
2023-12-31	AU$6.46 Million ≈ $4.57 Million	AU$-2.76 Million ≈ $-1.95 Million	-0.427x	+52.05%
2022-12-31	AU$9.16 Million ≈ $6.48 Million	AU$-8.15 Million ≈ $-5.77 Million	-0.890x	-20.68%
2021-12-31	AU$19.08 Million ≈ $13.50 Million	AU$-14.07 Million ≈ $-9.96 Million	-0.738x	-16.25%
2020-12-31	AU$35.65 Million ≈ $25.23 Million	AU$-22.62 Million ≈ $-16.01 Million	-0.635x	-38.40%
2019-12-31	AU$111.38 Million ≈ $78.81 Million	AU$-51.07 Million ≈ $-36.13 Million	-0.458x	-1154.74%
2018-12-31	AU$143.74 Million ≈ $101.70 Million	AU$-5.25 Million ≈ $-3.72 Million	-0.037x	-457.88%
2017-12-31	AU$99.09 Million ≈ $70.11 Million	AU$-649.00K ≈ $-459.21K	-0.007x	-103.27%
2005-12-31	AU$392.73 Million ≈ $277.88 Million	AU$78.77 Million ≈ $55.74 Million	0.201x	-52.91%
2004-12-31	AU$260.84 Million ≈ $184.56 Million	AU$111.09 Million ≈ $78.61 Million	0.426x	+53.92%
2003-12-31	AU$175.18 Million ≈ $123.95 Million	AU$48.47 Million ≈ $34.30 Million	0.277x	+43.04%
2002-12-31	AU$117.25 Million ≈ $82.96 Million	AU$22.68 Million ≈ $16.05 Million	0.193x	--

About Elixinol Wellness Ltd

AU:EXL Australia Drug Manufacturers - Specialty & Generic

Market Cap

$2.05 Million

AU$2.90 Million AUD

Market Cap Rank

#30074 Global

#1752 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$4.91